On June 24, 2026, Acting Attorney General of the United States Todd Blanche along with other senior government officials and leaders announced “the greatest combined federal and state effort in combating healthcare fraud in history.” The 2026 National Health Care Fraud Takedown heralded 455 defendants charged across 56 federal districts and 45 states and territories, in connection with more than $6.5 billion in alleged false claims submitted to Medicare, Medicaid, and other federal health programs—all in a coordinated two-week window.
The Numbers Behind the Headlines
The scale of the 2026 takedown, as reported, sets multiple records. According to Assistant Attorney General Colin McDonald of the United States Justice Department’s National Fraud Enforcement Division, the enforcement action spanned nine healthcare fraud strike forces, 56 U.S. Attorney offices, and 50 state Medicaid Fraud Control Units, including a record number of Medicaid-specific claims, with charges involving allegations of more than $518 million in Medicaid false claims. The government also reported seizing over $182 million in cash, luxury vehicles, and other assets.
Although the 2025 takedown involved a larger fraud figure ($14.6 billion), officials explained the difference as, in part, a sign of enforcement maturity: the government is now, according to officials, stopping allegedly fraudulent payments before they leave the Treasury rather than pursuing money after it has been disbursed. HHS Secretary Robert F. Kennedy Jr. described the prior approach as “pay and chase.” Secretary Kennedy stated that the “pay and chase” model has been replaced with a “detect and prevent” strategy deploying “advanced artificial intelligence and data analytics to identify fraudulent billing patterns in real time, stop improper payments before they occur, and strengthen oversight across federal health programs.”
Patient Harm Is the Central Narrative
What partially distinguishes this year’s announcement is its focus on patients in addition to taxpayers. AAG McDonald opened his remarks by stating that the underlying cases allege more than the theft of taxpayer dollars—they allege “the theft of human dignity.” He highlighted a cardiovascular testing case involving approximately $89 million in allegedly fraudulent claims, in which a medical director allegedly rubber-stamped ECG and echocardiogram results without reviewing them—in one instance, according to the charges, approving a test result within seconds of opening 63 images. One student athlete was allegedly cleared to play basketball despite having an enlarged heart two and a half times normal size, according to the government. He suffered sudden cardiac arrest and died on a basketball court weeks later. His mother’s message to the court was “The doctor is as bad as any greedy criminal who is killing people in the streets.” Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz presented this tragic outcome as emblematic of the stakes, stating at the announcement press conference: “Fraudsters, they, don’t care about you. If they’re willing to steal your money when you’re down and out and struggling…they will take your health and take your life.”
In another case highlighted by Andrew Ferguson of the White House Anti-Fraud Task Force, a nurse practitioner in Nevada is accused of billing Medicaid nearly $1 billion in skin substitute allografts allegedly applied to vulnerable elderly patients in hospices and nursing homes—then allegedly spending the proceeds on luxury items, which the government reported have since been seized.
A Smarter, Faster Enforcement Machine
The coordination of the enforcement effort behind this announced takedown reflects what officials described as a fundamental shift in how the government detects and prosecutes fraud. AAG McDonald announced three significant new capabilities: an agreement with CMS to access dedicated cloud computing space for real-time advanced analytics models; new data-sharing agreements with the Federal Trade Commission and Customs and Border Protection to eliminate information silos; and the debut prosecution from the Fraud Division’s new Financial Intelligence Review Team, brought within seven months of identifying a behavioral health provider in Illinois allegedly billing Medicaid $67 million in services the government contends were never delivered.
The allograft fraud cases highlighted during AAG McDonald’s remarks illustrate data-driven enforcement at its most consequential. According to the Department of Justice’s (DOJ) press release, the Health Care Fraud Unit’s Data Analytics Team identified a billing spike for amniotic wound allografts—from less than $1 billion in 2021 to over $14 billion in just four years. Criminal charges followed across six federal districts based on alleged fraud, and CMS simultaneously reduced reimbursement rates. The DOJ reported that the combined effect succeeded in reducing Medicare allograft billings from $14.4 billion to roughly $100 million since the start of this year.
CMS reported a fivefold increase in Medicare payment suspensions in the first half of 2026 compared to the same period last year, and a 400 percent increase in provider revocations in Q1. The DEA issued a record 928 administrative actions. And in a demonstration of international reach, the FBI reported executing four foreign transfer of custody operations on four separate continents within a single four-hour window, apprehending a fugitive in Turkey allegedly linked to a $1 billion fraud scheme, and, in the Philippines, an FBI Most Wanted fugitive allegedly tied to a $1.2 billion telemedicine scheme.
Implications for Healthcare Companies
The 2026 takedown announcement indicates a continuously operating enforcement infrastructure that is expanding in reach, sophistication, and speed.
Several implications follow:
- The government’s investment in real-time data analytics and cloud-based monitoring means that unusual spikes in billing will now surface on the government’s radar faster than before. The shift from “pay and chase” to “detect and prevent” means billing anomalies are being flagged and suspended in real time. Categories of claims flagged in this takedown include allografts, behavioral health, telemedicine, hospice, and cardiovascular testing.
- Medicaid enjoys equal enforcement priority. With 50 state Medicaid Fraud Control Units participating, the same compliance rigor must be applied to billing the Medicaid program as billing to Medicare.
- Individual liability remains an enforcement priority. Ninety licensed medical professionals were charged in this takedown, including physicians, nurse practitioners, and pharmacists. The cardiovascular testing case highlighted by AAG McDonald makes plain that apparent rubber-stamping of authorizations—whether for test results, prescriptions, or service orders—can create serious personal criminal exposure for the authorizing provider.
- The FBI’s four-continent, four-hour operation, combined with extraditions from Estonia, Turkey, and the Philippines, makes clear that operating or fleeing abroad is not an escape from accountability.
- Voluntary self-disclosure and proactive compliance remain the strongest defenses. The Fraud Division is generating, by AAG McDonald’s account, $100 in recovered taxpayer dollars for every dollar invested. DOJ policy continues to reward organizations that self-identify overpayments, disclose promptly, and cooperate fully. In an environment where real-time analytics can flag anomalies before investigators appear, the window between a billing irregularity and a government inquiry is shorter than it has ever been.
The Bottom Line
Real-time analytics and an expanding enforcement infrastructure have made it faster and more certain than ever before that billing anomalies will surface on the government’s radar, trigger payment suspensions, and prompt federal investigation. The government has successfully deployed enforcement capabilities enabling proactive monitoring of billing patterns and demonstrated that significant anomalies will trigger federal investigations.
Acting United States Attorney General Blanche described the 2026 takedown as “just the beginning,” and AAG McDonald closed his remarks with a pointed warning to providers who prioritize profit over patients. Whether or not those charged are ultimately convicted, the enforcement statistics and infrastructure described at the announcement suggest that government scrutiny of healthcare billing is intensifying. For healthcare companies navigating this environment, the practical message is clear: proactive compliance monitoring, thorough documentation, and prompt self-disclosure remain the most effective tools for managing regulatory and enforcement risk.
Written with the assistance of Caroline O’Reilly, a summer associate in Husch Blackwell’s Washington, DC office.